Advertisement
Screener

Zoetis Inc. (ZTS) Noncontrolling Interest, Decrease from Deconsolidation

Zoetis Inc. Noncontrolling Interest, Decrease from Deconsolidation

Zoetis Inc. (ZTS) reported Noncontrolling Interest, Decrease from Deconsolidation of $4.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-12.

Financial Statements › Shareholders' Equity › Noncontrolling Interest Items

us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2026-02-12

  • Zoetis Inc. noncontrolling interest, decrease from deconsolidation for the quarter ending 2024-12-31 was $0.00.
  • Zoetis Inc. noncontrolling interest, decrease from deconsolidation for the quarter ending 2024-09-30 was $4.00M.
  • Zoetis Inc. noncontrolling interest, decrease from deconsolidation for the quarter ending 2016-12-31 was $0.00.
  • Zoetis Inc. noncontrolling interest, decrease from deconsolidation for the quarter ending 2016-10-02 was $0.00.
  • Zoetis Inc. noncontrolling interest, decrease from deconsolidation for fiscal 2024 was $4.00M.
  • Zoetis Inc. noncontrolling interest, decrease from deconsolidation for fiscal 2016 was $6.00M.
Period endNoncontrolling Interest, Decrease from Deconsolidation 3 monthNoncontrolling Interest, Decrease from Deconsolidation 6 monthNoncontrolling Interest, Decrease from Deconsolidation 6 month as first filedNoncontrolling Interest, Decrease from Deconsolidation 9 monthNoncontrolling Interest, Decrease from Deconsolidation 12 month
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$4.00M
derived: sum of 2 quarters · filed 2026-02-12
$4.00M
10-K · filed 2026-02-12
2024-09-30$4.00M
10-Q · filed 2025-11-04
$4.00M
10-Q · filed 2025-11-04
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14
$0.00
derived: sum of 2 quarters · filed 2019-02-14
$6.00M
10-K · filed 2019-02-14
2016-10-02$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$6.00M
10-Q · filed 2017-11-02
2016-07-03$6.00M
10-Q · filed 2017-08-08
-$8.00M
10-Q · filed 2016-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10